bims-nakice Biomed News
on Natural killer cells
Issue of 2026–11–08
nine papers selected by
Santosh Phuyal, Oslo Universitetssykehus



  1. Exp Mol Pathol. 2026 Oct 31. pii: S0014-4800(26)00072-9. [Epub ahead of print]148 105093
      Natural killer (NK) cell therapy has emerged as a promising approach for cancer treatment. However, its efficacy is often limited by metabolic dysfunction, poor persistence, and reduced activity within the tumor microenvironment. Here, we investigated whether mitochondrial transfer could improve the metabolic fitness and antitumor activity of peripheral blood-derived primary NK cells. Using a simple centrifugation-based approach, mitochondria isolated from NK cells or umbilical cord-derived mesenchymal stem cells (UC-MSCs) were transferred into primary NK cells. Mitochondrial transfer significantly enhanced oxidative phosphorylation, glycolysis, and ATP production, leading to improved cytokine secretion and cytotoxicity against both hematologic and solid tumor targets. In xenograft models, mitochondrial transfer significantly suppressed tumor growth, with UC-MSCs-derived mitochondria producing the greatest therapeutic benefit. Proteomic analysis further revealed enrichment of pathways associated with immune activation, cellular migration, and cytoskeletal remodeling. Collectively, these findings demonstrate that mitochondrial transfer enhances NK-cell metabolic fitness and antitumor activity, highlighting its potential as a practical non-genetic strategy for improving NK cell-based cancer immunotherapy.
    Keywords:  Cell therapy; Immunometabolism; Metabolic reprogramming; Mitochondrial transfer; Natural killer cells; cancer immunotherapy
    DOI:  https://doi.org/10.1016/j.yexmp.2026.105093
  2. Front Cell Dev Biol. 2026 ;14 1927923
      Natural killer (NK) cell-based immunotherapy has become a research focus in cellular immunotherapy in recent years,which has advanced rapidly in the treatment of solid tumors. NK cells are key effector cells of innate immunity and can kill abnormal target cells without prior sensitization. A broad consensus holds that NK cell-based immunotherapy may become a new strategy for solid tumor treatment with lower risk and lower cost than T-cell-based immunotherapy. However, its translation from theory to clinical application remains constrained by relevant risks, and research on its cardiovascular safety is still largely absent. This review summarizes the latest research progress of NK cell-based immunotherapy in solid tumors and discusses its cardiovascular safety.
    Keywords:  CAR-NK; NK cell-based immunotherapy; cardiovascular safety; cell-based therapy; solid tumors
    DOI:  https://doi.org/10.3389/fcell.2026.1927923
  3. J Cell Sci. 2026 Nov 01. pii: jcs264858. [Epub ahead of print]139(21):
      Organelles communicate with each other by building membrane contact sites (MCSs) via specialized protein-protein and/or protein-membrane interactions. Conventional light microscopy cannot distinguish organelles connected by MCSs from those merely juxtaposed. In addition, organelle contacts are dynamic, yet only a limited number of tools are available to monitor MCSs in living cells. In this study, we developed a series of reporters based on dimerization-dependent fluorescent proteins (ddFP) to visualize, quantify and follow inter-organelle contacts. We first generated an integrated system specifically designed to study contacts between late endocytic compartments (late endosomes and lysosomes) and the endoplasmic reticulum (ER). This system utilizes a single plasmid coding for the two complementary ddFP components: green A (GA) and green B (GB) targeted to the ER and late endosomes and lysosomes (LE/Lys), respectively. This construct enabled the generation of a stable reporter cell line suitable for semi-quantitative imaging. The ddFP reporter, which we called ddFP LELYS-ER, did not perturb endogenous LE/Lys-ER contacts in stable cells, and detected changes in the number of LE/Lys-ER contacts, for example, upon downregulation of the ER-resident VAP tether protein family, or under conditions of lysosomal damage. Moreover, live-cell imaging revealed that LE/Lys-ER contacts have distinct shapes, mobilities and lifetimes. Finally, using the same vector design, we generated two additional integrated reporter systems adapted to the study of contacts between the ER and the plasma membrane, and between the ER and mitochondria.
    Keywords:  Dimerization-dependent fluorescent protein; Endoplasmic reticulum; Endosomes; Lysosomes; Membrane contact sites; Mitochondria; Organelles; Plasma membrane
    DOI:  https://doi.org/10.1242/jcs.264858
  4. J Genet Genomics. 2026 Nov 02. pii: S1673-8527(26)00337-1. [Epub ahead of print]
      Immunotherapy has revolutionized cancer care, yet resistance frequently undermines its efficacy. Although tumor-intrinsic resistance pathways have been mapped, how immune pressure regulates death-receptor vulnerability and anti-apoptotic buffering remains less defined. Using genome-wide CRISPR-Cas9 screening in cancer cells co-cultured with natural killer (NK) cells, we identify CFLAR, encoding cFLIP, as a dominant suppressor of death-receptor signaling that impairs NK- and T-cell cytotoxicity. CFLAR depletion sensitizes cancer cells to NK- and T-cell attack in vitro and in vivo. Single-cell and spatial transcriptomic analyses link high CFLAR expression to reduced lymphocyte infiltration and poorer responses to immune checkpoint blockade. Mechanistically, immune effector cell-induced inflammation increases CFLAR and death receptor 5 (DR5) expression in association with p38-MAPK signaling, balancing survival and death under immune pressure. The DR5 agonist conatumumab enhances lymphocyte-mediated killing and improves responses to cellular therapies, checkpoint blockade, and chemo-immunotherapy. Combining DR5 agonism with NKG2A blockade co-activates NK- and T-cell responses and overcomes anti-PD-1 resistance in MHC-I-deficient tumors. These findings identify the DR5-cFLIP axis as an immune-pressure-associated, pharmacologically targetable vulnerability and support rational combinations of DR5 agonists with multiple immunotherapies for refractory cancers.
    Keywords:  Apoptosis; CFLAR; Combination therapy; DR5; Immunotherapy
    DOI:  https://doi.org/10.1016/j.jgg.2026.10.015
  5. Cell Biol Int. 2026 Nov;pii: e70230. [Epub ahead of print]50(11):
      The primary function of the endoplasmic reticulum (ER) is co-translational translocation, modification, and folding of secretory, lysosomal, and transmembrane proteins. The ER is a highly dynamic organelle undergoing rapid structural and functional changes in response to intra- and extracellular signals. Accumulation within the ER of unfolded or misfolded proteins, termed ER stress, poses a lethal threat to cells. In response, cells activate a signaling cascade, called an unfolded protein response (UPR). UPR restores ER homeostasis by enhancing the organelle's folding capacity and reducing its protein load. ER stress in various cell types has often been associated with the formation of specific ER configuration, termed whorls. However, these structures appear under physiological conditions (or in models mimicking such states) and/or may be induced by natural stimuli such as high biosynthetic demand, physiological ER stress, or synthesis of cytotoxic compounds. Whorls can be stimulated in cells where they have not been previously documented, upon exposure to chemical ER stress/UPR inducers or following overexpression/mutation of ER membrane proteins. Under such conditions, cells may generate whorls to sequester and subsequently degrade aberrant, toxic, or overproduced proteins and membranes. Cells appear to utilize whorls to modulate metabolic activity, store proteins and membranes, and isolate or degrade damaged, toxic, or excessed substrates. In this context, whorls formation may have pro-survival rather than pro-death function. It seems that whorls in different organisms and cell types exhibit only phenotypic convergence, with distinct biogenesis mechanisms having evolved independently and not being universally present across all cell types.
    Keywords:  OSER; endoplasmic reticulum stress; sequestration; whorls
    DOI:  https://doi.org/10.1002/cbin.70230
  6. Cell Death Discov. 2026 Aug 10. pii: 445. [Epub ahead of print]12(1):
      SELENOF is an understudied selenoprotein that contains selenium in the form of selenocysteine. Our previous findings indicate that SELENOF likely functions as a tumor suppressor in breast cancer; however, its precise molecular role and regulatory mechanisms remain poorly understood. SELENOF localizes to the endoplasmic reticulum (ER) through a strong association with UDP-glucose glycoprotein glucosyltransferase 1 (UGGT1) and is thought to participate in protein folding quality control. Impaired protein folding efficiency leads to the accumulation of unfolded or misfolded proteins, thereby inducing ER stress and activating the unfolded protein response (UPR), an adaptive signaling network that restores ER homeostasis. Whether SELENOF modulates the UPR specifically in mammary epithelial cells and how this impacts cellular outcomes remain unknown. Here, we demonstrate that SELENOF establishes a feedforward regulatory loop with the inositol-requiring enzyme 1α (IRE1α) and X-box binding protein 1 (XBP1) arm of the UPR. SELENOF expression is upregulated by ER stress through the IRE1α-XBP1 pathway in normal immortalized human epithelial cells, murine mammary glands, and human breast cancer cells, thereby amplifying UPR signaling. In cancer cells, SELENOF overexpression exacerbates UPR activation, leading to IRE1α-dependent cell death. Conversely, SELENOF loss in normal breast epithelial cells limits the UPR to adaptive levels, allowing cells to evade senescence. Moreover, silencing UGGT1, a key enzyme in the glycan quality control pathway and interacting partner of SELENOF, reduced SELENOF protein levels and phenocopied its effects in limiting stress-induced activation of the IRE1-XBP1s axis of the UPR. Collectively, these findings identify SELENOF as a critical modulator of the UPR and highlight a complex and context-dependent role for SELENOF and IRE1α-UPR in breast tumorigenesis.
    DOI:  https://doi.org/10.1038/s41420-026-03285-7
  7. Elife. 2026 Nov 04. pii: RP107123. [Epub ahead of print]14
      The cell NAD+/NADH ratio can constrain biomass synthesis and influence proliferation in nutrient-limited environments. However, which cell processes regulate the NAD+/NADH ratio is not known. Here, we find that some cancer cells elevate the NAD+/NADH ratio in response to serine deprivation by increasing mitochondrial respiration. Cancer cells that elevate mitochondrial respiration have higher serine production and proliferation in serine-limiting conditions than cells with no mitochondrial respiration response, independent of serine synthesis enzyme expression. Increases in mitochondrial respiration and the NAD+/NADH ratio promote serine synthesis regardless of whether serine is environmentally limiting. Lipid deprivation can increase the NAD+/NADH ratio via mitochondrial respiration in some cells, including cells that do not increase respiration following serine deprivation. Thus, in cancer cells where lipid depletion raises the NAD+/NADH ratio, proliferation in serine-depleted environments improves when lipids are also depleted. Taken together, these data suggest that changes in mitochondrial respiration in response to nutrient deprivation can influence the NAD+/NADH ratio in a cell-specific manner to impact oxidative biomass synthesis and proliferation. Given the complexity of tumor microenvironments, this work provides a metabolic framework for understanding how levels of more than one environmental nutrient affect cancer cell proliferation.
    Keywords:  NAD+/NADH ratio; biochemistry; cancer biology; cancer metabolism; chemical biology; human; lipid depletion; mitochondria; serine
    DOI:  https://doi.org/10.7554/eLife.107123
  8. Mol Biol Cell. 2026 Nov 05. mbcE26040159
      Lipid droplets (LDs) are dynamic organelles that store neutral lipids and form in the endoplasmic reticulum (ER) membrane. Formation of new LDs is a controlled process and requires proteins with specific functions to form and grow from the ER membrane without any defect. In vitro studies have suggested a role for membrane curvature in LD emergence from the ER. Here, we use the reticulon-like membrane-shaping protein Pex30 to investigate the impact of ER membrane curvature on LD biogenesis and morphology. We modified the reticulon homology domain (RHD) of Pex30, which is responsible for tubulating the ER membrane, by extending the short hairpin transmembrane domains (TMD). The Pex30 (TMD) mutants cannot tubulate the ER membrane and generate less local membrane curvature than WT Pex30. Additionally, these mutants are unable to restore delayed LD biogenesis observed in cells devoid of Pex30. Our results indicate that Pex30 RHD generates local membrane curvature at ER subdomains that drives formation of new LDs.
    DOI:  https://doi.org/10.1091/mbc.E26-04-0159